These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 9047307)

  • 1. Mutations in the carboxyl terminus of the agouti protein decrease agouti inhibition of ligand binding to the melanocortin receptors.
    Kiefer LL; Ittoop OR; Bunce K; Truesdale AT; Willard DH; Nichols JS; Blanchard SG; Mountjoy K; Chen WJ; Wilkison WO
    Biochemistry; 1997 Feb; 36(8):2084-90. PubMed ID: 9047307
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Melanocortin receptor binding determinants in the agouti protein.
    Kiefer LL; Veal JM; Mountjoy KG; Wilkison WO
    Biochemistry; 1998 Jan; 37(4):991-7. PubMed ID: 9454589
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Role of melanocortinergic neurons in feeding and the agouti obesity syndrome.
    Fan W; Boston BA; Kesterson RA; Hruby VJ; Cone RD
    Nature; 1997 Jan; 385(6612):165-8. PubMed ID: 8990120
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Agouti antagonism of melanocortin-4 receptor: greater effect with desacetyl-alpha-melanocyte-stimulating hormone (MSH) than with alpha-MSH.
    Mountjoy KG; Willard DH; Wilkison WO
    Endocrinology; 1999 May; 140(5):2167-72. PubMed ID: 10218968
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Melanocortin receptor-mediated mobilization of intracellular free calcium in HEK293 cells.
    Mountjoy KG; Kong PL; Taylor JA; Willard DH; Wilkison WO
    Physiol Genomics; 2001 Feb; 5(1):11-9. PubMed ID: 11161002
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characterization of Agouti-related protein binding to melanocortin receptors.
    Yang YK; Thompson DA; Dickinson CJ; Wilken J; Barsh GS; Kent SB; Gantz I
    Mol Endocrinol; 1999 Jan; 13(1):148-55. PubMed ID: 9892020
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Agouti protein inhibits growth of B16 melanoma cells in vitro by acting through melanocortin receptors.
    Siegrist W; Willard DH; Wilkison WO; Eberle AN
    Biochem Biophys Res Commun; 1996 Jan; 218(1):171-5. PubMed ID: 8573126
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The yellow mouse obesity syndrome and mechanisms of agouti-induced obesity.
    Moussa NM; Claycombe KJ
    Obes Res; 1999 Sep; 7(5):506-14. PubMed ID: 10509609
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Receptor-antagonist interactions in the complexes of agouti and agouti-related protein with human melanocortin 1 and 4 receptors.
    Chai BX; Pogozheva ID; Lai YM; Li JY; Neubig RR; Mosberg HI; Gantz I
    Biochemistry; 2005 Mar; 44(9):3418-31. PubMed ID: 15736952
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The agouti gene product inhibits lipolysis in human adipocytes via a Ca2+-dependent mechanism.
    Xue B; Moustaid-N ; Wilkison WO; Zemel MB
    FASEB J; 1998 Oct; 12(13):1391-6. PubMed ID: 9761782
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Induction of neuropeptide Y gene expression in the dorsal medial hypothalamic nucleus in two models of the agouti obesity syndrome.
    Kesterson RA; Huszar D; Lynch CA; Simerly RB; Cone RD
    Mol Endocrinol; 1997 May; 11(5):630-7. PubMed ID: 9139806
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role of the central melanocortin system in cachexia.
    Marks DL; Ling N; Cone RD
    Cancer Res; 2001 Feb; 61(4):1432-8. PubMed ID: 11245447
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Molecular interaction of Agouti protein and Agouti-related protein with human melanocortin receptors.
    Tota MR; Smith TS; Mao C; MacNeil T; Mosley RT; Van der Ploeg LH; Fong TM
    Biochemistry; 1999 Jan; 38(3):897-904. PubMed ID: 9893984
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification of putative agouti-related protein(87-132)-melanocortin-4 receptor interactions by homology molecular modeling and validation using chimeric peptide ligands.
    Wilczynski A; Wang XS; Joseph CG; Xiang Z; Bauzo RM; Scott JW; Sorensen NB; Shaw AM; Millard WJ; Richards NG; Haskell-Luevano C
    J Med Chem; 2004 Apr; 47(9):2194-207. PubMed ID: 15084118
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Melanocortin receptors and antagonists regulate pigmentation and body weight.
    Jordan SA; Jackson IJ
    Bioessays; 1998 Aug; 20(8):603-6. PubMed ID: 9780833
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Agouti antagonism of melanocortin binding and action in the B16F10 murine melanoma cell line.
    Blanchard SG; Harris CO; Ittoop OR; Nichols JS; Parks DJ; Truesdale AT; Wilkison WO
    Biochemistry; 1995 Aug; 34(33):10406-11. PubMed ID: 7544613
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Agouti regulation of intracellular calcium: role of melanocortin receptors.
    Kim JH; Kiefer LL; Woychik RP; Wilkison WO; Truesdale A; Ittoop O; Willard D; Nichols J; Zemel MB
    Am J Physiol; 1997 Mar; 272(3 Pt 1):E379-84. PubMed ID: 9124542
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Agouti: from mouse to man, from skin to fat.
    Voisey J; van Daal A
    Pigment Cell Res; 2002 Feb; 15(1):10-8. PubMed ID: 11837451
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Agouti/melanocortin interactions with leptin pathways in obesity.
    Zemel MB
    Nutr Rev; 1998 Sep; 56(9):271-4. PubMed ID: 9763877
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Differential effects of melanocortin peptides on neural melanocortin receptors.
    Adan RA; Cone RD; Burbach JP; Gispen WH
    Mol Pharmacol; 1994 Dec; 46(6):1182-90. PubMed ID: 7808440
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.